50
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
0.214
Exchange
XHKG - Hong Kong Exchange
-20 %
Last period Net income growth rate
32%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also Lansen Pharmaceutical
Company Analysis
503.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
503.HK financial analysis by Eyestock methodology
Valuation
503.HK valuation using historical relative method
Statements
503.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
503.HK dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
Lansen Pharmaceutical`s Net income growth rate for the period ended 2023-06-30 is -20 %
